Latest News and Press Releases
Want to stay updated on the latest news?
-
Applied StemCell uses TARGATT™ tech to insert a 50 kb multifunctional DNA construct into hiPSCs, enabling development of allogeneic iPSC-based therapies.
-
Applied StemCell welcomes Dolores Baksh, Ph.D., as new CEO.
-
Applied StemCell launches hiEX™ Research iPSC Exosomes, designed as a scalable and consistent source of exosomes for regenerative medicine research.